Provided by Tiger Trade Technology Pte. Ltd.

Accendra Health Inc

0.5627
-0.0493-8.06%
Post-market: 0.56400.0013+0.23%19:30 EDT
Volume:2.00M
Turnover:1.15M
Market Cap:43.27M
PE:-0.14
High:0.6346
Open:0.6200
Low:0.5544
Close:0.6120
52wk High:5.60
52wk Low:0.5544
Shares:76.90M
Float Shares:56.51M
Volume Ratio:1.25
T/O Rate:3.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.9457
EPS(LYR):-14.3179
ROE:-198.35%
ROA:0.64%
PB:-0.08
PE(LYR):-0.04

Loading ...

Dec 31, 2025

Major Issues Report

Form 8-K - Current report
Dec 18, 2025

Major Issues Report

Form 8-K - Current report
Dec 08, 2025

Major Issues Report

Form 8-K - Current report
Dec 02, 2025

Major Issues Report

Form 8-K - Current report
Oct 31, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 30, 2025

Major Issues Report

Form 8-K - Current report
Oct 07, 2025

Major Issues Report

Form 8-K - Current report
Sep 19, 2025

Major Issues Report

Form 8-K - Current report
Aug 11, 2025

Major Issues Report

Form 8-K - Current report
Aug 11, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 06, 2025

Major Issues Report

Form 8-K - Current report
Jun 05, 2025

Major Issues Report

Form 8-K - Current report
Apr 25, 2023

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Aug 31, 2022

[Rev.]Annual Report

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Aug 22, 2022

Voluntary Delisting

25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
Aug 10, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jul 19, 2022

Correspondence

CORRESP [Cover] - Correspondence
Apr 22, 2022

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Apr 27, 2021

important event

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 22, 2021

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]